Dynamic coupling of 99mTc-MIBI efflux and apoptotic pathway activation in untreated breast cancer patients

European Journal of Nuclear Medicine

Volumn 29, Issue 6, 2002, Pages 809-814

  Del Vecchio, Silvana ^a   Zannetti, Antonella ^a   Ciarmiello, Andrea ^b   Aloj, Luigi ^a   Caracò, Corradina ^c   Fonti, Rosa ^a   Botti, Gerardo ^b   D'Aiuto, Giuseppe ^b   Salvatore, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

^c CNR   (Italy)

Author keywords

99mTc MIBI efflux; Apoptosis; Breast cancer; Multidrug resistance

Indexed keywords

GLYCOPROTEIN P; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DNA FRAGMENT; MONOCLONAL ANTIBODY KI 67; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT; TUMOR MARKER;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMAGING; MITOCHONDRION; NICK END LABELING; TUMOR CELL; CELL ACTIVATION; CHEMICAL LABELING; CLEARANCE; HUMAN CELL; INHIBITION KINETICS; PROTEIN FUNCTION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TIME; BIOLOGICAL MODEL; BREAST TUMOR; LUNG CARCINOMA; METABOLIC CLEARANCE RATE; METABOLISM; MIDDLE AGED; PAGET NIPPLE DISEASE; PATHOLOGY; SCINTISCANNING; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; HUMANS; METABOLIC CLEARANCE RATE; MIDDLE AGED; MODELS, BIOLOGICAL; NEOPLASM RECURRENCE, LOCAL; P-GLYCOPROTEIN; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TUMOR MARKERS, BIOLOGICAL;

EID: 0036596882     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-002-0773-x     Document Type: Article

References (29)

1. Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance
2. Multidrug resistance transporters and modulation
3. Imaging multidrug resistance with radiolabeled substrates for P-glycoprotein and multidrug resistance protein
4. In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
5. Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer
6. Cancer multidrug resistance
7. Pharmacologic approaches to reversing multidrug resistance
8. Drug resistance mechanisms in acute leukemia
9. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576
10. Non-P-glycoprotein drug export mechanisms of multidrug resistance
11. Apoptosis in the pathogenesis and treatment of disease
12. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
13. Molecular characterization of mitochondrial apoptosis-inducing factor
14. Apoptosis in breast cancer as related to histopathological characteristics and prognosis
15. bcl-2 and apoptosis in lymph node positive breast carcinoma
16. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers
17. Induction of apoptosis by cancer chemotherapy
18. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation
19. Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma
20. Quantitative comparison of apoptosis to cell proliferation and p53 protein in breast carcinomas
21. Number of apoptotic cells as a prognostic marker in invasive breast cancer
22. A matter of life and cell death
23. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion
24. Uptake and retention of hexakis (2-methoxyisobutyl isonitrile) technetium(I) in cultured chick myocardial cells. Mitochondrial and plasma membrane potential dependence
25. Uptake of the cation hexakis(2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro
26. Mitochondria and apoptosis
27. Mitochondria as the central control point of apoptosis
28. Mitochondria as regulators of apoptosis: Doubt no more
29. Cell death in the third millennium